Clinical outcome of advanced and metastatic renal cell carcinoma treated with targeted therapy: is there a difference between young and old patients?

BACKGROUND: To assess whether the clinical outcome of advanced and metastatic renal cell carcinoma (mRCC) treated with targeted therapy differs between young and old patients. PATIENTS AND METHODS: A total of 327 patients with advanced renal cell carcinoma and mRCC who received targeted therapy in t...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Onco Targets Ther
Hlavní autoři: Zhang, Guiming, Zhu, Yao, Dong, Dahai, Gu, Weijie, Zhang, Hailiang, Sun, Lijiang, Ye, Dingwei
Médium: Artigo
Jazyk:Inglês
Vydáno: Dove Medical Press 2014
Témata:
Original Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4224101/
https://ncbi.nlm.nih.gov/pubmed/25395863
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S70012
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky